NFKB1 and neoplasm: The anti-tumorigenic effect of gastrin is thought to be caused in part by suppression of the epigenetic silencing of Tff1, which encodes a tumor suppressor that attenuates nuclear factor kappa B (NF–κB) signaling [44,45].